Suven Life Sciences Limited (SUVEN) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.368x

Based on the latest financial reports, Suven Life Sciences Limited (SUVEN) has a cash flow conversion efficiency ratio of -0.368x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-1.03 Billion ≈ $-11.18 Million USD) by net assets (Rs2.81 Billion ≈ $30.42 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Suven Life Sciences Limited (SUVEN) defensive interval to measure how many days the company can operate on defensive assets alone.

Suven Life Sciences Limited - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Suven Life Sciences Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Suven Life Sciences Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Suven Life Sciences Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Hangzhou Gaoxin Rubber & Plastic Materials Co Ltd
SHE:300478
-0.422x
Global Top E Commerce Co Ltd
SHE:002640
-0.326x
Tianma Bearing Group Co Ltd
SHE:002122
0.003x
Sgis Songshan Co Ltd
SHE:000717
0.093x
Golden Entertainment Inc
NASDAQ:GDEN
0.062x
SUPER HI INTERNATIONAL HOLDING LTD. American Depositary Shares
NASDAQ:HDL
0.087x
UBISOFT ENTMT ADR 1/5
F:UEN0
N/A
Sirio Pharma
SHE:300791
0.038x

Annual Cash Flow Conversion Efficiency for Suven Life Sciences Limited (2005–2025)

The table below shows the annual cash flow conversion efficiency of Suven Life Sciences Limited from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see SUVEN market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs1.10 Billion
≈ $11.89 Million
Rs-1.48 Billion
≈ $-16.06 Million
-1.350x -215.69%
2024-03-31 Rs2.70 Billion
≈ $29.20 Million
Rs-1.15 Billion
≈ $-12.49 Million
-0.428x -55.59%
2023-03-31 Rs3.75 Billion
≈ $40.59 Million
Rs-1.03 Billion
≈ $-11.16 Million
-0.275x +79.28%
2022-03-31 Rs961.45 Million
≈ $10.40 Million
Rs-1.28 Billion
≈ $-13.79 Million
-1.327x -49.20%
2021-03-31 Rs1.08 Billion
≈ $11.68 Million
Rs-960.24 Million
≈ $-10.38 Million
-0.889x +34.25%
2020-03-31 Rs1.43 Billion
≈ $15.50 Million
Rs-1.94 Billion
≈ $-20.96 Million
-1.352x -3261.03%
2019-03-31 Rs8.31 Billion
≈ $89.87 Million
Rs355.49 Million
≈ $3.84 Million
0.043x -53.06%
2018-03-31 Rs7.67 Billion
≈ $82.99 Million
Rs699.36 Million
≈ $7.56 Million
0.091x -44.15%
2017-03-31 Rs6.67 Billion
≈ $72.13 Million
Rs1.09 Billion
≈ $11.77 Million
0.163x +39.04%
2016-03-31 Rs5.95 Billion
≈ $64.40 Million
Rs698.78 Million
≈ $7.56 Million
0.117x -54.10%
2015-03-31 Rs5.59 Billion
≈ $60.49 Million
Rs1.43 Billion
≈ $15.46 Million
0.256x -44.27%
2014-03-31 Rs2.64 Billion
≈ $28.60 Million
Rs1.21 Billion
≈ $13.12 Million
0.459x +130.90%
2013-03-31 Rs1.54 Billion
≈ $16.70 Million
Rs306.86 Million
≈ $3.32 Million
0.199x -24.39%
2012-03-31 Rs1.28 Billion
≈ $13.79 Million
Rs335.07 Million
≈ $3.62 Million
0.263x +503.70%
2011-03-31 Rs1.27 Billion
≈ $13.71 Million
Rs55.16 Million
≈ $596.55K
0.044x -60.24%
2010-03-31 Rs1.18 Billion
≈ $12.77 Million
Rs129.25 Million
≈ $1.40 Million
0.109x -63.45%
2009-03-31 Rs1.14 Billion
≈ $12.38 Million
Rs342.73 Million
≈ $3.71 Million
0.299x +709.03%
2008-03-31 Rs1.06 Billion
≈ $11.51 Million
Rs39.38 Million
≈ $425.92K
0.037x -76.86%
2007-03-31 Rs1.02 Billion
≈ $10.98 Million
Rs162.41 Million
≈ $1.76 Million
0.160x +161.76%
2006-03-31 Rs902.12 Million
≈ $9.76 Million
Rs55.13 Million
≈ $596.25K
0.061x +135.07%
2005-03-31 Rs811.85 Million
≈ $8.78 Million
Rs21.11 Million
≈ $228.26K
0.026x --

About Suven Life Sciences Limited

NSE:SUVEN India Drug Manufacturers - Specialty & Generic
Market Cap
$740.67 Million
Rs68.49 Billion INR
Market Cap Rank
#10414 Global
#516 in India
Share Price
Rs259.70
Change (1 day)
-1.16%
52-Week Range
Rs126.65 - Rs296.60
All Time High
Rs296.60
About

Suven Life Sciences Limited, a clinical-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel therapeutics for the treatment of neurodegenerative disorders in India, the United States, Europe, and internationally. The company engages in drug discovery and development of new chemical entities in central nervous system diseases. Its product candida… Read more